As a medical student and researcher, I was shocked by the brazen inequity of the trial.  Randomized controlled trials have ...

Preeclampsia can be deadly in pregnancy, and aside from delivering the baby, the condition has no targeted treatment. A new ...

A data-driven, collaborative program failed to lead to noticeable gains in the trial, but a researcher says the search isn’t ...

Multiple system atrophy (MSA) is an adult-onset, rapidly progressive neurodegenerative disorder characterised by the aggregation of α-synuclein in oligodendroglial cytoplasmatic inclusions.1 ...

Patients with chronic kidney disease are often taken off RAS inhibitors after declines in kidney function, but the risks may ...

At a Senate hearing on Wednesday, Robert F. Kennedy, Jr., referred to ibogaine as the most promising treatment for PTSD and ...

In October 2024, Calluna Pharma concluded the Phase I clinical study of its lead product, CAL101, for fibrotic and ...

Seventeen placebo-controlled trials across seven antibodies yielded statistically significant but clinically small mean ...

The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

In this letter, we examine not one but three meta-analyses of randomized controlled trials to explore a provocative question: ...

An external statistical blinded review of ACTION3 data has achieved its objective by confirming that the study remains appropriately statistically powered (>90%) to demonstrate a treatment effect for ...

One of the world's oldest medicines may have a powerful new purpose. A growing body of clinical evidence suggests that aspirin, the common painkiller with roots stretching back 4,000 years, can ...